Clay B. Siegall - 30 Dec 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
30 Dec 2025
Net transactions value
+$100,018
Form type
4
Filing time
30 Dec 2025, 18:47:24 UTC
Previous filing
22 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SIEGALL CLAY B President and CEO, Director C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 30 Dec 2025 0001167496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $100,018 +4,729 +0.72% $21.15 665,254 30 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.